Calamos Advisors’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17M | Buy |
63,696
+15,825
| +33% | +$4.38M | 0.06% | 303 |
|
|
2025
Q4 | $13.2M | Sell |
47,871
-1,944
| -4% | -$545K | 0.05% | 338 |
|
|
2025
Q3 | $14.4M | Hold |
49,815
| – | – | 0.05% | 341 |
|
|
2025
Q2 | $16.5M | Hold |
49,815
| – | – | 0.06% | 307 |
|
|
2025
Q1 | $16.4M | Buy |
49,815
+555
| +1% | +$167K | 0.07% | 294 |
|
|
2024
Q4 | $13.6M | Hold |
49,260
| – | – | 0.06% | 340 |
|
|
2024
Q3 | $17.1M | Sell |
49,260
-1,209
| -2% | -$416K | 0.07% | 299 |
|
|
2024
Q2 | $16.7M | Sell |
50,469
-1,842
| -4% | -$635K | 0.07% | 282 |
|
|
2024
Q1 | $19M | Sell |
52,311
-1,316
| -2% | -$433K | 0.09% | 256 |
|
|
2023
Q4 | $16.1M | Sell |
53,627
-700
| -1% | -$205K | 0.08% | 299 |
|
|
2023
Q3 | $15.5M | Hold |
54,327
| – | – | 0.08% | 302 |
|
|
2023
Q2 | $15.2M | Hold |
54,327
| – | – | 0.08% | 316 |
|
|
2023
Q1 | $13.9M | Sell |
54,327
-6,790
| -11% | -$1.98M | 0.07% | 346 |
|
|
2022
Q4 | $20.3M | Sell |
61,117
-10,806
| -15% | -$3.42M | 0.1% | 260 |
|
|
2022
Q3 | $20M | Hold |
71,923
| – | – | 0.09% | 257 |
|
|
2022
Q2 | $19M | Buy |
71,923
+1,937
| +3% | +$499K | 0.08% | 271 |
|
|
2022
Q1 | $16.8M | Buy |
69,986
+9,327
| +15% | +$2.18M | 0.06% | 343 |
|
|
2021
Q4 | $13.9M | Buy |
60,659
+2,348
| +4% | +$499K | 0.05% | 395 |
|
|
2021
Q3 | $11.7M | Buy |
58,311
+5,145
| +10% | +$1.12M | 0.05% | 381 |
|
|
2021
Q2 | $12.6M | Buy |
53,166
+12,093
| +29% | +$3.02M | 0.06% | 343 |
|
|
2021
Q1 | $9.93M | Buy |
41,073
+1,269
| +3% | +$283K | 0.05% | 337 |
|
|
2020
Q4 | $8.29M | Sell |
39,804
-1,724
| -4% | -$338K | 0.05% | 371 |
|
|
2020
Q3 | $7.04M | Sell |
41,528
-3,695
| -8% | -$650K | 0.05% | 383 |
|
|
2020
Q2 | $8.49M | Sell |
45,223
-2,840
| -6% | -$539K | 0.06% | 334 |
|
|
2020
Q1 | $8.52M | Sell |
48,063
-4,096
| -8% | -$795K | 0.07% | 296 |
|
|
2019
Q4 | $10.7M | Sell |
52,159
-855
| -2% | -$157K | 0.05% | 330 |
|
|
2019
Q3 | $8.05M | Buy |
53,014
+4,604
| +10% | +$749K | 0.04% | 395 |
|
|
2019
Q2 | $7.63M | Sell |
48,410
-18,797
| -28% | -$2.95M | 0.04% | 406 |
|
|
2019
Q1 | $10.8M | Sell |
67,207
-473
| -0.7% | -$86.4K | 0.07% | 299 |
|
|
2018
Q4 | $12.9M | Buy |
67,680
+29,048
| +75% | +$6.06M | 0.08% | 268 |
|
|
2018
Q3 | $8.04M | Buy |
38,632
+15,719
| +69% | +$2.91M | 0.04% | 353 |
|
|
2018
Q2 | $3.89M | Sell |
22,913
-21,961
| -49% | -$3.8M | 0.02% | 497 |
|
|
2018
Q1 | $7.53M | Buy |
44,874
+2,024
| +5% | +$393K | 0.05% | 360 |
|
|
2017
Q4 | $8.7M | Sell |
42,850
-884
| -2% | -$176K | 0.04% | 318 |
|
|
2017
Q3 | $8.18M | Buy |
43,734
+1,559
| +4% | +$278K | 0.06% | 308 |
|
|
2017
Q2 | $7.06M | Buy |
42,175
+1,086
| +3% | +$174K | 0.05% | 332 |
|
|
2017
Q1 | $6.02M | Buy |
41,089
+1,086
| +3% | +$160K | 0.05% | 342 |
|
|
2016
Q4 | $5.34M | Sell |
40,003
-537
| -1% | -$70.3K | 0.04% | 340 |
|
|
2016
Q3 | $5.28M | Buy |
40,540
+40
| +0.1% | +$5.22K | 0.04% | 344 |
|
|
2016
Q2 | $5.18M | Buy |
40,500
+15
| +0% | +$1.98K | 0.04% | 337 |
|
|
2016
Q1 | $5.56M | Buy |
40,485
+2,526
| +7% | +$347K | 0.04% | 318 |
|
|
2015
Q4 | $5.55M | Sell |
37,959
-950
| -2% | -$131K | 0.04% | 327 |
|
|
2015
Q3 | $5.25M | Sell |
38,909
-1,087
| -3% | -$158K | 0.04% | 339 |
|
|
2015
Q2 | $6.48M | Sell |
39,996
-13,349
| -25% | -$1.84M | 0.04% | 335 |
|
|
2015
Q1 | $6.91M | Buy |
53,345
+17,660
| +49% | +$2.05M | 0.04% | 322 |
|
|
2014
Q4 | $3.67M | Buy |
35,685
+185
| +0.5% | +$18.2K | 0.02% | 397 |
|
|
2014
Q3 | $3.22M | Hold |
35,500
| – | – | 0.02% | 386 |
|
|
2014
Q2 | $3.27M | Hold |
35,500
| – | – | 0.02% | 390 |
|
|
2014
Q1 | $2.97M | Hold |
35,500
| – | – | 0.02% | 392 |
|
|
2013
Q4 | $3.11M | Hold |
35,500
| – | – | 0.02% | 378 |
|
|
2013
Q3 | $2.73M | Hold |
35,500
| – | – | 0.02% | 379 |
|
|
2013
Q2 | $2.57M | Buy |
+35,500
| New | +$2.39M | 0.02% | 371 |
|
Other funds holding CI
VCM
VPM
Calamos Advisors's CI Position: Q1 2026 in Review
Calamos Advisors increased its Cigna (CI) stake by 33% in Q1 2026, buying an estimated $4.38M and bringing the position to 63,696 shares worth $17M. The position accounts for 0.06% of the portfolio, ranked #303.
Calamos Advisors first reported a position in CI in Q2 2013 and has held it in 52 quarters since. The position peaked at $20.3M in Q4 2022. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.
- Calamos Advisors held 63,696 shares of Cigna worth $17M as of Q1 2026.
- Calamos Advisors bought 15,825 Cigna shares in Q1 2026, an estimated $4.38M.
- Cigna made up 0.06% of Calamos Advisors's portfolio in Q1 2026, its #303 holding.
- Calamos Advisors first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
- Calamos Advisors's Cigna position peaked at $20.3M in Q4 2022.
- 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.
Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.